arrow
C

Camille N. Kotton

massachusetts general hospital
H指数:48
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Pritelivir Versus Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial

普拉提利韦与福司卡奈特治疗阿昔洛韦耐药单纯疱疹病毒感染在免疫抑制成人中的疗效与安全性:一项随机、开放标签二期试验

2026-08-310
OAAI
Outcomes of Respiratory Syncytial Virus Infection in Patients with Systemic Autoimmune Rheumatic Disease

系统性自身免疫性风湿病患者的呼吸道合胞病毒感染结局

2025-10-040
PRE
A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation

一种基于细胞介导免疫的移植后巨细胞病毒感染预后评分

2025-07-080
OAAI
Zero-shot large language model application for surgical site infection auditing

零样本大语言模型在手术部位感染审核中的应用

2025-05-220
PRE
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials

免疫功能低下患者难治性和耐药性单纯疱疹病毒黏膜皮肤感染:文献综述及临床试验中拟用定义

2025-01-291
OA
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
2025-01-211
OAAI